Ocular Therapeutix announces upcoming conference presentations

(Image credit: ©Patricia E. Thomas/AdobeStock)

Ocular Therapeutix announced the company’s conference participation in the upcoming annual OIS Retina Innovation Summit, the American Society of Retina Specialists (ASRS), and Women in Ophthalmology (WIO) meetings.¹

The company will be presenting 2 sessions at OIS Retina 2025 in Long Beach, California:

• Company presentation: Ocular Therapeutix
  • Tuesday, July 29, 2025, 11 AM to 12:35 PM PT
  • Session: Spotlight on Drug Delivery
  • Presenter: Sanjay Nayak, MBBS, PhD, Chief Strategy Officer
• Panel: Spotlight on Drug Delivery
  • Tuesday, July 29, 2025, 11 AM to 1:35 PM PT
  • Presenter: Peter K. Kaiser, MD, Chief Development Officer

The company will have a presentation and a poster at ASRS 2025 in Long Beach:

• Presentation: Longitudinal Quantitative Ultra-Widefield Retinal Leakage Assessment in Diabetic Retinopathy Following a Single Axitinib Hydrogel (OTX-TKI) in the HELIOS Trial
  • Thursday, July 31, 2025, 11:35 AM to 12:15 PM PT
  • Session: Diabetic Retinopathy Symposium 2
  • Presenter: Katherine Talcott, MD
• Poster: Macular Volumetric Fluid Outcomes Following Treatment with Intravitreal Axitinib Hydrogel (OTX-TKI) in Non-Proliferative Diabetic Retinopathy
  • Thursday, July 31, 2025, 9:30 AM to 6:30 PM PT
  • Presenter: Devesh Kumar, MD

The company is presenting 1 poster at WIO 2025 in Amelia Island, FL:

• Poster: Macular Fluid Volume and Retinal Vascular Leakage Analysis Following a Single Axitinib Intravitreal Hydrogel in Diabetic Retinopathy
  • Saturday, August 9, 2025, 11 AM to noon ET and Sunday, August 10, 2025, 9:45 to 10:45 AM ET
  • Presenter: Diana Do, MD

Ocular Therapeutix is a biopharmaceutical company with its investigational candidate, AXPAXLI (OTX-TKI). AXPAXLI is an axitinib intravitreal hydrogel currently in phase 3 clinical trials for treating wet age-related macular degeneration.¹

Reference:

1. Globenewswire.com. Published 2025. Accessed July 22, 2025. https://www.globenewswire.com/news-release/2025/07/22/3119284/0/en/Ocular-Therapeutix-to-Participate-in-Upcoming-Scientific-Conferences.htmlhttps://www.globenewswire.com/news-release/2025/07/22/3119284/0/en/Ocular-Therapeutix-to-Participate-in-Upcoming-Scientific-Conferences.html